Health News

Health News

RSS Feed

Raludotatug Deruxtecan Demonstrated Clinically Meaningful Response Rates in Patients with Recurrent Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer in Phase 2 Part of REJOICE-Ovarian01 Phase 2/3 Trial

8:45 AM on Sunday, October 19

DATROWAY® (datopotamab deruxtecan-dlnk) demonstrated unprecedented median overall survival improvement of five months vs. chemo as 1st-line treatment for patients with metastatic triple-negative breast cancer for whom immunotherapy was not an option

7:00 AM on Sunday, October 19

DATROWAY® Demonstrated an Unprecedented Median Overall Survival Improvement of Five Months Vs Chemotherapy as First-line Treatment for Patients with Metastatic Triple Negative Breast Cancer for Whom Immunotherapy Was Not an Option in TROPION-Breast02

2:30 AM on Sunday, October 19

KEYTRUDA® (pembrolizumab) Plus Chemotherapy With or Without Bevacizumab Reduced Risk of Disease Progression or Death Versus Chemotherapy With or Without Bevacizumab in Certain Patients With Platinum-Resistant Recurrent Ovarian Cancer

10:35 AM on Saturday, October 18

ENHERTU® (fam-trastuzumab deruxtecan-nxki) reduced the risk of disease recurrence or death by 53% vs. T-DM1 in patients with high-risk HER2-positive early breast cancer following neoadjuvant therapy in DESTINY-Breast05 Phase III trial

10:35 AM on Saturday, October 18

KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) Reduced Risk of Event-Free Survival Events by 60% and Risk of Death by 50% for Certain Patients with Muscle-Invasive Bladder Cancer When Given Before and After Surgery

10:30 AM on Saturday, October 18

ENHERTU® (fam-trastuzumab deruxtecan-nxki) followed by THP before surgery resulted in a pathologic complete response in 67% of patients with high-risk HER2-positive early-stage breast cancer in DESTINY-Breast11 Phase III trial

10:30 AM on Saturday, October 18

ENHERTU® Reduced the Risk of Disease Recurrence or Death by 53% Versus T-DM1 in Patients with High-Risk HER2 Positive Early Breast Cancer Following Neoadjuvant Therapy in DESTINY-Breast05 Phase 3 Trial

10:30 AM on Saturday, October 18

Nurse Rod Salaysay plays guitar for patient Richard Hoang in the recovery unit of UC San Diego Health in San Diego, Calif., on Sept. 30, 2025. (AP Photo/Javier Arciga)

Music could help ease pain from surgery or illness. Scientists are listening

9:04 AM on Saturday, October 18

Hospitals and doctors' offices are inviting singers and musicians to help patients manage their pain, as music's ability to reduce pain is gaining attention

First ... 25 26 27 28 29 ... Last

Salem News Channel Today

Sponsored Links

On Air & Up Next

  • The Voice of Reason
    3:00PM - 5:00PM
     
    The Voice of Reason is a nationally syndicated conservative talk show that   >>
     
  • Veterans Radio America
    5:00PM - 6:00PM
     
    Veterans Radio is a Service-Disabled Veteran-Owned Small Business (SDVOSB)   >>
     
  • Retire Right with Shawn Mueller
    7:00PM - 8:00PM
     
    Shawn’s mission is to help provide every client with targeted, comprehensive   >>
     
  • The Chris Stigall Show
    8:00PM - 10:00PM
     
    Equal parts hilarity and desk-pounding monologues with healthy doses of skepticism and sarcasm.
     
  • Armed American Radio
    10:00PM - 11:00PM
     
    Armed American Radio is the official radio program of The United States Concealed Carry Association.
     

See the Full Program Guide